Potential Leukocytic Toxicity
Induce by Vinorelbine,
Doxorubicin and Cisplatin
in Human Patients of Breast,
Cervix and Lung Cancer

Taha Nazir; Nida Taha; Muzhar Mustafa; Azharul Islam; Adeel Mahmood; Saeed ur Rasheed Nazir

doi:10 .4172/2327-4581.1000411

Research Article, Prensa Med Argent Vol: 101 Issue: 6

Potential Leukocytic Toxicity Induce by Vinorelbine, Doxorubicin and Cisplatin in Human Patients of Breast, Cervix and Lung Cancer

Abstract

Potential Leukocytic Toxicity Induce by Vinorelbine, Doxorubicin and Cisplatin in Human Patients of Breast, Cervix and Lung Cancer

Anticancer drugs are used extensively in chemotherapy. Bone marrow suppression is one of their major side effects. Therefore, we aimed this study to investigate the potential leukocytic toxicity induced by vinorelbine in cancer patients. The data of total 60 adult patients were selected and divided into two groups; Group-1 patients received Vinorelbine alone and group-2 Vinorelbine based combinations. The outcomes demonstrated no statistically important difference in the patients who were either on vinorelbine alone, vinorelbine plus cisplatin or vinorelbine plus doxorubicin combinations.